General Fusion Group Ltd. (Nasdaq: GFUZ) began trading on Nasdaq on July 13, 2026, three days after closing the business combination that turned the Vancouver fusion developer into a US reporting issuer. The company said it entered the public markets with approximately US$150 million in cash, inclusive of net transaction proceeds from the private placement and trust capital. Its shell company report on Form 20-F, filed with the Securities and Exchange Commission, sets out the machinery behind that headline: a cross-border continuation, an amalgamation, a private placement that raised more than two thirds of the money, and a redemption that emptied most of the trust.

How the transaction was assembled

The deal rested on a Business Combination Agreement dated January 21, 2026, amended on May 12, 2026 and again on June 3, 2026, among Spring Valley Acquisition Corp. III, a Cayman Islands exempted company, General Fusion Inc., a British Columbia limited company, and 1573562 B.C. Ltd., a wholly owned Spring Valley subsidiary. Closing required four moves in sequence. Spring Valley transferred by way of continuation and deregistration from the Cayman Islands to British Columbia. It changed its name to General Fusion Group Ltd. It adopted new articles under which its Class A shares were redesignated as subordinate voting shares. The subsidiary then amalgamated with General Fusion Inc., and the subordinate voting shares were listed on Nasdaq. The 20-F gives July 10, 2026 as the closing date, so the first trade on July 13 came three days after the corporate steps were complete.

The financing ran alongside the structure. General Fusion and Spring Valley entered securities purchase agreements for a private investment in public equity for total gross proceeds of $107.7 million. Investors agreed to buy an aggregate of 10,556,367 units at $10.20 per unit, each unit made up of one convertible preferred share and one warrant exercisable for a common share at $12.00. The units were bought at the old company and immediately exchanged for equivalent securities of the listed entity, where the preferred shares became multiple voting shares. Management and the board of Spring Valley were replaced at closing by the General Fusion team.

The vote and the redemptions

Spring Valley held its extraordinary general meeting on July 6, 2026, on a proxy statement and prospectus filed on June 12, 2026 and mailed to shareholders on or about June 15, 2026. As of the record date there were approximately 23,000,000 Class A ordinary shares and 7,666,667 Class B ordinary shares outstanding. A total of 17,402,874 ordinary shares, roughly 56.74% of the shares entitled to vote, were present in person or by proxy.

Support among those who voted was lopsided. The continuation proposal carried with 16,760,091 votes for, 642,282 against and 501 abstentions. The business combination proposal itself drew 16,760,217 for, 642,282 against and 375 abstentions. The advisory proposal to rewrite the authorized share capital was the least popular item on the agenda, passing with 15,401,149 for and 2,000,344 against.

Approval and participation are separate questions from cash. The pro forma capitalization table in the 20-F carries a footnote stating that it reflects redemptions of 21,075,896 shares in connection with the business combination. Set against the roughly 23,000,000 public shares outstanding at the record date, that leaves a small residue of trust money, which is why the company describes its cash as inclusive of both private placement proceeds and trust capital rather than trust capital alone.

What the balance sheet looked like

The 20-F presents an unaudited pro forma combined capitalization as of December 31, 2025, giving effect to the transaction. Stated in thousands of US dollars, it shows cash and cash equivalents of 169,626, current liabilities of 73,108 and long-term liabilities of 87,644. Redeemable convertible preferred shares from the private placement, 10,556,373 of them, sit in temporary equity at 106,256. Common shares are carried at 365,406 against an accumulated deficit of 444,666 and accumulated other comprehensive loss of 6,704, producing total shareholders’ equity of negative 85,964 and total capitalization of 64,865.

The share count is layered. The company reports 52,988,419 common shares outstanding, an unlimited number of authorized preferred shares with none outstanding, 10,556,373 multiple voting shares, and three classes of earnout shares each authorized at 4,500,000 with 3,173,061, 3,173,060 and 3,173,060 respectively outstanding. Public warrants trade under GFUZW and carry an exercise price of $11.50. The private placement warrants are exercisable at $12.00.

Analysis: the filing and the press release are measuring different things

The US$150 million figure and the 169,626 in the pro forma table are not competing versions of the same number. The first is what management says the company held after closing on July 10, 2026. The second is a modelled figure as of December 31, 2025 that applies the transaction to a year-end balance sheet. A reader comparing them is comparing a statement about July with an accounting construction about the prior December, and the gap between them is not evidence of anything by itself.

The redemption footnote is the more informative number. With 21,075,896 shares redeemed against approximately 23,000,000 Class A shares outstanding on the record date, almost all of the trust was redeemed before closing. The $107.7 million private placement therefore did most of the work of funding the company, and it did so on terms that sit senior to the ordinary shareholder: the preferred shares became multiple voting shares, they carry accruing dividends described in the proxy, and they come with warrants at $12.00. The beneficial ownership table is computed on 63,544,792 subordinate voting shares rather than the 52,988,419 outstanding, because it deems exercisable derivative securities to be outstanding. A blocker provision caps certain holders at 9.9% of the subordinate voting shares, which suppresses reported percentages without removing the underlying dilution.

A later filing adds a governance detail that post-dates the trading debut. On August 17, 2026 the board concluded, on its audit committee’s recommendation and after discussion with the auditor, that Spring Valley’s condensed consolidated financial statements for the quarter ended March 31, 2026 should no longer be relied upon, because the estimated fair value of a non-cash subscription liability had been overstated. The company says the liability never touched cash and was extinguished at closing, so it will not appear in any General Fusion financial statement. What the disclosure establishes is that a pre-closing shell period will be restated in an amended Form 10-Q. What it does not establish is whether a material weakness will be identified, and the 6-K lists that possibility among its risks. The amended report is the document to read next.

Since the listing

General Fusion rang the Nasdaq opening bell on July 17, 2026 and gave its first business update as a public company on August 18, 2026. The company said the cash raised is expected to fund the Lawson Machine 26 program through several planned technical milestones to the end of 2028. On the physics, it reported plasma heating to approximately 0.72 keV, or 8.4 million degrees Celsius, using compression of a plasma with a lithium liner, against a near-term target of 1 keV and later objectives of 10 keV and the Lawson criterion. It also described a milestone-based framework agreement with Renexia S.p.A. on possible deployment in Italy and a collaboration with General Atomics Energy Group on diagnostics able to measure above 10 keV.

“Our listing on Nasdaq marks an important milestone for General Fusion and the broader fusion industry,” chief executive Greg Twinney said in the August update, in which he also set out an objective of a first-of-a-kind fusion plant by approximately 2035. At the listing itself he had said the company is “dedicated to our vision of bringing practical, clean, and abundant fusion energy to the world”. The company was established in 2002, says it has run more than 200,000 plasma experiments, and describes LM26 as operating at 50% of commercial-scale diameter on current design parameters. None of that is revenue, and the company’s own risk disclosure includes the possibility that it never generates any.